NASDAQ:INOV Inovalon Stock Forecast, Price & News Notice: This company has been marked as potentially delisted and may not be actively trading. Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Inovalon Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Add Compare Share Today's Range$41.06▼$41.0650-Day Range$40.66▼$41.0652-Week Range$17.56▼$41.06VolumeN/AAverage Volume720,587 shsMarket Capitalization$6.37 billionP/E Ratio120.76Dividend YieldN/APrice Target$34.67 ProfileAnalyst RatingsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability Receive INOV Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter. Email Address INOV Stock Forecast (MarketRank)Overall MarketRank™1.60 out of 5 starsComputer And Technology Sector631st out of 937 stocksData Processing & Preparation Industry63rd out of 114 stocksAnalyst Opinion: 1.1Community Rank: 4.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 - 1.1 Analyst's Opinion Consensus RatingInovalon has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 1 buy rating, 4 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $34.67, Inovalon has a forecasted downside of 15.6% from its current price of $41.06.Amount of Analyst CoverageInovalon has received no research coverage in the past 90 days. Previous Next 4.0 Community Rank Outperform VotesInovalon has received 348 “outperform” votes. (Add your “outperform” vote.)Underperform VotesInovalon has received 223 “underperform” votes. (Add your “underperform” vote.)Community SentimentInovalon has received 60.95% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Inovalon and other stocks. Vote “Outperform” if you believe INOV will outperform the S&P 500 over the long term. Vote “Underperform” if you believe INOV will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldInovalon does not currently pay a dividend.Dividend GrowthInovalon does not have a long track record of dividend growth. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Inovalon insiders have not sold or bought any company stock.Percentage Held by Insiders49.75% of the stock of Inovalon is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 33.15% of the stock of Inovalon is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Inovalon are expected to grow by 11.67% in the coming year, from $0.60 to $0.67 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Inovalon is 120.76, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 34.55.Price to Earnings Ratio vs. SectorThe P/E ratio of Inovalon is 120.76, which means that it is trading at a more expensive P/E ratio than the Computer and Technology sector average P/E ratio of about 81.39.Price to Earnings Growth RatioInovalon has a PEG Ratio of 2.99. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioInovalon has a P/B Ratio of 8.31. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Inovalon (NASDAQ:INOV)Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.Read More INOV Stock News HeadlinesJune 27, 2022 | marketwatch.comPatient Data Analytics Market Outlook By Product, Application, End-User & Forecast By 2030June 15, 2022 | finance.yahoo.comKajeet's Chief Technology Officer Greg Jones and Director of Strategy and Business Development Dominic Marcellino to Present at 2022 IoT Evolution Expo - Yahoo FinanceMay 31, 2022 | finance.yahoo.comA $88 Billion Global Opportunity for Healthcare Analytics by 2026 - New Research from StrategyR - Yahoo FinanceMay 12, 2022 | finance.yahoo.comCorEvitas, LLC and Inovalon Highlight Data Linkage Efficiencies at ISPOR - Yahoo FinanceMay 3, 2022 | finance.yahoo.comStan Opstad Joins Zipari as Chief Product Officer - Yahoo FinanceApril 18, 2022 | bizjournals.comBaltimore-area billionaires see their net worth rise on Forbes 2022 ranking — all except one - Baltimore Business Journal - The Business JournalsMarch 30, 2022 | finance.yahoo.comHealthcare Analytics Market Size & Share 2022 | North America, Europe, & APAC Industry Forecasts 2028: Graphical Research - Yahoo FinanceMarch 29, 2022 | finance.yahoo.comGLOBAL HEALTHCARE ANALYTICS MARKET FORECAST 2022-2030 - Yahoo FinanceMarch 29, 2022 | globenewswire.comAmerican Oncology Network Taps Inovalon to Support Efficient, Reliable Delivery of Oral Oncology Medications - GlobeNewswireMarch 15, 2022 | finance.yahoo.comPharmacare Hawaii Selects Inovalon to Ensure Best Clinical Outcomes for Specialty and Infusion Pharmacy Patients - Yahoo FinanceMarch 14, 2022 | globenewswire.comInovalon Launches Registration Assurance Solution for Healthcare Providers - GlobeNewswireMarch 14, 2022 | globenewswire.comPharmacare Hawaii Selects Inovalon to Ensure Best Clinical - GlobeNewswireMarch 8, 2022 | businesswire.comJessie J and Deborah Cox to Headline 2022 Florida AIDS Walk & Musicfest - Business WireSee More Headlines Industry, Sector and Symbol Stock ExchangeNASDAQ Industry Data processing & preparation Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:INOV CUSIPN/A CIK1619954 Webwww.inovalon.com Phone(301) 809-4000Fax301-809-8060Employees1,836Year FoundedN/ACompany Calendar Last Earnings7/28/2021Today7/01/2022Fiscal Year End12/31/2022Price Target and Rating Average Stock Price Forecast$34.67 High Stock Price Forecast$41.00 Low Stock Price Forecast$23.00 Forecasted Upside/Downside-15.6%Consensus RatingHold Rating Score (0-4)2.2 Research Coverage5 Analysts Profitability EPS (Most Recent Fiscal Year)$0.34 Trailing P/E Ratio120.76 Forward P/E Ratio68.43 P/E Growth2.99Net Income$22.58 million Net Margins6.73% Pretax Margin5.86% Return on Equity10.97% Return on Assets4.10% Debt Debt-to-Equity Ratio1.17 Current Ratio2.40 Quick Ratio2.40 Sales & Book Value Annual Sales$667.52 million Price / Sales9.55 Cash Flow$1.23 per share Price / Cash Flow33.35 Book Value$4.94 per share Price / Book8.31Miscellaneous Outstanding Shares155,246,000Free Float78,011,000Market Cap$6.37 billion OptionableOptionable Beta0.53 Inovalon Frequently Asked Questions Should I buy or sell Inovalon stock right now? 5 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inovalon in the last twelve months. There are currently 4 hold ratings and 1 buy rating for the stock. The consensus among Wall Street research analysts is that investors should "hold" Inovalon stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INOV, but not buy additional shares or sell existing shares. View analyst ratings for Inovalon or view top-rated stocks. What is Inovalon's stock price forecast for 2022? 5 equities research analysts have issued 12 month price targets for Inovalon's shares. Their INOV stock forecasts range from $23.00 to $41.00. On average, they anticipate Inovalon's stock price to reach $34.67 in the next year. This suggests that the stock has a possible downside of 15.6%. View analysts' price targets for Inovalon or view top-rated stocks among Wall Street analysts. How were Inovalon's earnings last quarter? Inovalon Holdings, Inc. (NASDAQ:INOV) issued its earnings results on Wednesday, July, 28th. The technology company reported $0.19 earnings per share for the quarter, beating analysts' consensus estimates of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to the consensus estimate of $183.89 million. Inovalon had a net margin of 6.73% and a trailing twelve-month return on equity of 10.97%. View Inovalon's earnings history. Who are Inovalon's key executives? Inovalon's management team includes the following people: Keith R. Dunleavy, Chairman & Chief Executive OfficerEron S. Kelly, PresidentJonathan R. Boldt, Chief Financial & Accounting Officer (LinkedIn Profile)Paige C. Kilian, Chief Medical OfficerMonica Keeneth, Chief Information Security Officer & VP What is Keith R. Dunleavy's approval rating as Inovalon's CEO? 410 employees have rated Inovalon CEO Keith R. Dunleavy on Glassdoor.com. Keith R. Dunleavy has an approval rating of 57% among Inovalon's employees. This puts Keith R. Dunleavy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. Who are some of Inovalon's key competitors? Some companies that are related to Inovalon include Bilibili (BILI), Clarivate (CLVT), Zynga (ZNGA), Zendesk (ZEN), Change Healthcare (CHNG), Globant (GLOB), DXC Technology (DXC), TELUS International (Cda) (TIXT), Toast (TOST), Five9 (FIVN), Playtika (PLTK), Autohome (ATHM), RingCentral (RNG), Pegasystems (PEGA) and PagSeguro Digital (PAGS). View all of INOV's competitors. What other stocks do shareholders of Inovalon own? Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Square (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH). When did Inovalon IPO? (INOV) raised $500 million in an IPO on Thursday, February 12th 2015. The company issued 22,200,000 shares at a price of $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank acted as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers. What is Inovalon's stock symbol? Inovalon trades on the NASDAQ under the ticker symbol "INOV." What is Inovalon's stock price today? One share of INOV stock can currently be purchased for approximately $41.06. How much money does Inovalon make? Inovalon (NASDAQ:INOV) has a market capitalization of $6.37 billion and generates $667.52 million in revenue each year. The technology company earns $22.58 million in net income (profit) each year or $0.34 on an earnings per share basis. How many employees does Inovalon have? Inovalon employs 1,836 workers across the globe. How can I contact Inovalon? Inovalon's mailing address is 4321 COLLINGTON ROAD, BOWIE MD, 20716. The official website for Inovalon is www.inovalon.com. The technology company can be reached via phone at (301) 809-4000, via email at [email protected], or via fax at 301-809-8060. This page (NASDAQ:INOV) was last updated on 7/1/2022 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply. MarketBeat Resources Premium Research Tools MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools. Discover All Access Market Data and Calendars Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free. View Market Data Investing Education and Resources Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more. Financial Terms Details Here